PT  - JOURNAL ARTICLE
AU  - Hugo Bourdon
AU  - Vittoria Aragno
AU  - Christophe Baudouin
AU  - Antoine Labbé
TI  - Iridoplasty for plateau iris syndrome: a systematic review
AID  - 10.1136/bmjophth-2019-000340
DP  - 2019 Sep 01
TA  - BMJ Open Ophthalmology
PG  - e000340
VI  - 4
IP  - 1
4099  - http://bmjophth.bmj.com/content/4/1/e000340.short
4100  - http://bmjophth.bmj.com/content/4/1/e000340.full
SO  - BMJ Open Ophth2019 Sep 01; 4
AB  - Plateau iris syndrome (PIS) is a frequent cause of angle closure. Argon laser peripheral iridoplasty (ALPI) has been proposed in PIS to widen the iridocorneal angle. The objective of the present study was to perform a systematic review of the available studies evaluating the efficacy of ALPI on intraocular pressure (IOP), iridocorneal angle opening and the number of medications in patients with chronic angle-closure associated with PIS. One prospective and seven retrospective studies with a minimum 1 month of follow-up were included. Although ALPI seemed to lower IOP, to decrease the number of topical antiglaucoma medications and widen the iridocorneal angle shortly after the procedure, there is no current evidence of long-term efficacy. To date, there is no robust scientific evidence to advocate ALPI as a treatment for chronic angle-closure caused by PIS.